one digital central, Top stories

Sudan and South Sudan extended the opening hours of the humanitarian corridor between the two countries, and the governments of Sudan and South Sudan signed an agreement on December 9 local time to extend the opening hours of the humanitarian corridor between the two countries until February 2 next year. According to the agreement, air routes from South Sudan to Kadugli, the capital of South Kordofan State in Sudan, and Garad and Kaunau will continue to be open to facilitate the delivery of humanitarian aid from South Sudan to Sudan. After the agreement expires on February 2 next year, the two sides will also discuss the extension.Violation of equity incentive plan? Tesla was fined 70,000 yuan. Recently, Tesla Motors (Beijing) Co., Ltd. was fined 70,000 yuan by the Beijing Branch of the State Administration of Foreign Exchange for violating foreign exchange registration regulations. The types of illegal acts involve Articles 2 and 8 of the Notice of the State Administration of Foreign Exchange on Relevant Issues Concerning Domestic Individuals Participating in Foreign Exchange Management of Equity Incentive Plans of Overseas Listed Companies. According to the above law, the equity incentive plan of Tesla Motors (Beijing) Co., Ltd. may be illegal. (21 Finance)Afternoon comment: The Shanghai Composite Index rose more than 1% in half a day, and consumer concept stocks broke out collectively. The index was active in early trading. The Shanghai Composite Index rose more than 1% in half a day, and the Shanghai Composite Index rose more than 2%. In terms of sectors, robot concept stocks continued to break out, and the concept of PEEK materials led the rise. Both China Research Institute and Xinyi New Materials had a daily limit of 20cm, while Zhongxin Fluorescent Materials and Walter shares touched the daily limit; The large consumer sector collectively rose, with dairy stocks leading the gains, and Panda Dairy, Western Animal Husbandry and Li Ziyuan were trading daily; AI concept stocks fluctuated higher, and it is worth buying 20cm daily limit, Hanwang Technology, Xinhua Media and other daily limit; Insurance stocks strengthened, and Tianli Technology, Astar, Focus Technology and other daily limit. Overall, individual stocks showed a general upward trend, with more than 4,600 stocks rising. On the disk, all sectors in the two cities generally rose, with PEEK materials, film and television theaters and dairy sectors among the top gainers.

The fund sentiment continues to pick up, and the rebound of A shares is expected to continue! Half-day turnover of Shanghai and Shenzhen 300ETF South (159925) exceeded 90 million yuan. By midday on December 10th, Shanghai and Shenzhen 300ETF South (159925) had increased by 1.83%, with a turnover of 90299400 yuan. Component stocks rose strongly, with China Ping An, China Merchants Bank and Wuliangye rising by over 3%, while Kweichow Moutai, Midea Group and Contemporary Amperex Technology Co., Limited rising by over 2%. In the news, the Political Bureau of the Communist Party of China (CPC) Central Committee held a meeting on December 9th to analyze and study the economic work in 2025. The meeting stressed that it is necessary to "implement more active and promising macro policies." Galaxy Securities said that looking forward to the market outlook, from the macro event point of view, the US interest rate cut is expected to heat up in December, and the superimposed domestic PMI data performed well. The follow-up policy stimulus and financial data are expected to support the continuous recovery of capital sentiment, which can be appropriately optimistic. In addition, there have been many discussions on the upcoming meeting recently, and there are still strong expectations for stimulus policies. Next, the policy landing will be an important factor affecting whether the market style can be changed. If the fundamentals are expected to improve, the large and medium-sized stocks are expected to change their trend. We can pay attention to the opportunities of medium-term investment, that is, look for the turning point of the industry boom in 2025, such as new energy, medicine, advanced manufacturing, Hong Kong stock Internet and so on.It is said that Li Zhenyu, senior vice president of Baidu Group, left his post. According to media reports, Li Zhenyu, senior vice president of Baidu Group, assistant to CEO and former general manager of intelligent driving business group, has left his post. At present, no personal information can be found in the internal system. Sina Technology asked Baidu Group about this. As of press time, there is no official response. (Sina Technology)Australian Treasury Secretary chalmers: The new A $2 billion expenditure on natural disaster preparedness will affect the mid-year economic and financial outlook.

Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.